Yuh‐Ping Chong

412 total citations
11 papers, 304 citations indexed

About

Yuh‐Ping Chong is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yuh‐Ping Chong has authored 11 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Yuh‐Ping Chong's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Protein Tyrosine Phosphatases (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Yuh‐Ping Chong is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Protein Tyrosine Phosphatases (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Yuh‐Ping Chong collaborates with scholars based in Australia, United States and Canada. Yuh‐Ping Chong's co-authors include Heung‐Chin Cheng, Terrence D. Mulhern, Donald J. Fujita, Jeffrey D. Bjorge, Glen M. Scholz, Daisy Lio, Hong‐Jian Zhu, Anthony W. Purcell, Bořivoj Vojtěšek and Edwina C. Lerner and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Pathology and Journal of Hospital Infection.

In The Last Decade

Yuh‐Ping Chong

10 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuh‐Ping Chong Australia 7 219 70 46 40 30 11 304
Marieta Gencheva United States 13 334 1.5× 42 0.6× 48 1.0× 18 0.5× 26 0.9× 24 461
Scott Langdon United States 11 189 0.9× 31 0.4× 51 1.1× 18 0.5× 56 1.9× 15 358
Cristina Escribano Spain 7 279 1.3× 92 1.3× 122 2.7× 61 1.5× 13 0.4× 10 408
Nhan Nguyen United States 11 244 1.1× 80 1.1× 184 4.0× 55 1.4× 34 1.1× 15 439
Hongyu Bao China 11 317 1.4× 48 0.7× 29 0.6× 36 0.9× 38 1.3× 22 358
Tessa Humphries‐Bickley Puerto Rico 5 253 1.2× 79 1.1× 23 0.5× 127 3.2× 9 0.3× 6 359
Kristen Bisanz United States 6 287 1.3× 124 1.8× 37 0.8× 47 1.2× 18 0.6× 7 389
Anna Lyakisheva Canada 7 211 1.0× 45 0.6× 31 0.7× 16 0.4× 9 0.3× 11 299
Anton Chestukhin Israel 9 244 1.1× 139 2.0× 20 0.4× 92 2.3× 16 0.5× 14 359
Satoko Shimamura United Kingdom 4 264 1.2× 84 1.2× 24 0.5× 50 1.3× 33 1.1× 5 373

Countries citing papers authored by Yuh‐Ping Chong

Since Specialization
Citations

This map shows the geographic impact of Yuh‐Ping Chong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuh‐Ping Chong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuh‐Ping Chong more than expected).

Fields of papers citing papers by Yuh‐Ping Chong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuh‐Ping Chong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuh‐Ping Chong. The network helps show where Yuh‐Ping Chong may publish in the future.

Co-authorship network of co-authors of Yuh‐Ping Chong

This figure shows the co-authorship network connecting the top 25 collaborators of Yuh‐Ping Chong. A scholar is included among the top collaborators of Yuh‐Ping Chong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuh‐Ping Chong. Yuh‐Ping Chong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chong, Yuh‐Ping, et al.. (2023). SARS-CoV-2 Testing Strategies in the Diagnosis and Management of COVID-19 Patients in Low-Income Countries: A Scoping Review. Molecular Diagnosis & Therapy. 27(3). 303–320. 6 indexed citations
2.
Chong, Yuh‐Ping, et al.. (2023). Screening for and diagnosis of monoclonal gammopathy. Journal of Clinical Pathology. 76(11). 727–733. 1 indexed citations
3.
Jung, Jiwon, So Lun Lee, Hyo Jin Park, et al.. (2022). Risk of transmission of COVID-19 from healthcare workers returning to work after a 5-day isolation, and kinetics of shedding of viable SARS-CoV-2 variant B.1.1.529 (Omicron). Journal of Hospital Infection. 131. 228–233. 7 indexed citations
5.
Narayan, Vikram, Petr Halada, Lenka Hernychová, et al.. (2011). A Multiprotein Binding Interface in an Intrinsically Disordered Region of the Tumor Suppressor Protein Interferon Regulatory Factor-1. Journal of Biological Chemistry. 286(16). 14291–14303. 22 indexed citations
6.
Cheng, Heung‐Chin, et al.. (2009). Allosteric networks governing regulation and catalysis of Src‐family protein tyrosine kinases: Implications for disease‐associated kinases. Clinical and Experimental Pharmacology and Physiology. 37(1). 93–101. 8 indexed citations
7.
Chong, Yuh‐Ping, Nicholas A. Williamson, Edwina C. Lerner, et al.. (2006). C-terminal Src Kinase-homologous Kinase (CHK), a Unique Inhibitor Inactivating Multiple Active Conformations of Src Family Tyrosine Kinases. Journal of Biological Chemistry. 281(44). 32988–32999. 34 indexed citations
8.
Cheng, Heung‐Chin, et al.. (2006). Csk homologous kinase. 3 indexed citations
9.
Chong, Yuh‐Ping, et al.. (2005). Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1754(1-2). 210–220. 92 indexed citations
10.
Chong, Yuh‐Ping, Terrence D. Mulhern, & Heung‐Chin Cheng. (2005). C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)—endogenous negative regulators of Src-family protein kinases. Growth Factors. 23(3). 233–244. 84 indexed citations
11.
Chong, Yuh‐Ping, Terrence D. Mulhern, Hong‐Jian Zhu, et al.. (2004). A Novel Non-catalytic Mechanism Employed by the C-terminal Src-homologous Kinase to Inhibit Src-family Kinase Activity. Journal of Biological Chemistry. 279(20). 20752–20766. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026